Universitätsklinikum Hamburg-Eppendorf has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Germany. Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are OSAKA PREFECTURAL HOSPITAL ORGANIZATION, RAMBAM MED TECH LTD and Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Germany | 1 | |
#4 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Measuring electric variables | |
#6 | Diagnosis and surgery | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Fuchs Tobias | 3 |
#2 | Ruprecht Christian | 2 |
#3 | Izbicki Jakob R | 2 |
#4 | Stahl Phillip | 2 |
#5 | Kording Fabian | 2 |
#6 | Perez Daniel | 2 |
#7 | Konczalla Leonie | 2 |
#8 | Fehrs Kai-Kristoph | 2 |
#9 | Wiech Thorsten | 2 |
#10 | Stahl Rolf | 2 |
Publication | Filing date | Title |
---|---|---|
EP3273238A1 | Immunodiagnostic detection of anti-neutrophil antibodies | |
EP3225997A1 | Thsd7a as a novel target for cancer therapy and diagnosis | |
WO2016138899A1 | Improved immunodiagnostic detection of anti-neutrophil antibodies | |
EP3181055A1 | Ultrasonic device for detecting the heartbeat of a patient | |
DE102015210224A1 | NEW ACTIVE FOR THE TREATMENT OF CANCER | |
EP2876163A1 | DNA aptamers specifically binding E- and P-Selectins |